Mononuclear cells from patients recovered from cutaneous leishmaniasis respond to Leishmania major amastigote class I nuclease with a predominant Th1-like response.
The Leishmania major amastigote class I nuclease (LmaCIN) is a developmentally regulated protein that is highly expressed in the amastigote stage of L. major. This protein is homologous to the P4 nuclease of L. pifanoi, which has been shown to induce protective immune response in a murine model. To evaluate LmaCIN as a potential human vaccine candidate, cellular immune responses to recombinant LmaCIN were examined in individuals recovered from Old World cutaneous leishmaniasis. Peripheral blood mononuclear cells (PBMC) from patients recovered from L. major infection were cultured either with recombinant LmaCIN or autoclaved L. major (ALM) as control. rLmaCIN induced significant proliferation of PBMC from 90% of recovered patients. Phenotypic analysis of proliferating cells showed that CD8(+) cells were the predominant cell type proliferating in response to rLmaC1N. Screening of culture supernatants for cytokines showed that rLmaCIN induced high levels of interferon (IFN)-gamma (mean +/- s.e.m.: 1398 +/- 179 pg/ml) associated with little interleukin (IL)-10 and little or no IL-5 production. These findings show that LmaCIN is immunogenic in humans during L. major infection and that it can elicit immunological responses relevant to immunoprophylaxis of leishmaniasis.
Farajnia
S
S
Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Mahboudi
F
F
Ajdari
S
S
Reiner
N E
NE
Kariminia
A
A
Alimohammadian
M H
MH
D000704:Analysis of Variance; D000953:Antigens, Protozoan / Q000276:immunology*; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology; D016022:Case-Control Studies; D049109:Cell Proliferation; D006801:Humans; D007371:Interferon-gamma / Q000276:immunology; D016753:Interleukin-10 / Q000276:immunology; D015848:Interleukin-5 / Q000276:immunology; D016773:Leishmaniasis, Cutaneous / Q000276:immunology* / Q000628:therapy; D007963:Leukocytes, Mononuclear / Q000276:immunology*; D008213:Lymphocyte Activation; D016052:Protozoan Vaccines / Q000494:pharmacology*; D018417:Th1 Cells / Q000276:immunology*; D014614:Vaccines, Synthetic / Q000494:pharmacology
D000953:Antigens, Protozoan; D015848:Interleukin-5; D016052:Protozoan Vaccines; D014614:Vaccines, Synthetic; D016753:Interleukin-10; D007371:Interferon-gamma
J Exp Med. 2001 Nov 19;194(10):1497-506
11714756
Clin Exp Immunol. 2001 May;124(2):255-61
11422202
Clin Diagn Lab Immunol. 2002 Mar;9(2):251-6
11874860
J Immunol. 2002 Apr 15;168(8):3992-4000
11937556
Nat Rev Immunol. 2002 Nov;2(11):845-58
12415308
Parasitol Int. 2002 Dec;51(4):367-79
12421635
Vaccine. 2002 Dec 13;21(3-4):174-80
12450691
Clin Exp Immunol. 2003 May;132(2):316-22
12699423
Infect Immun. 2003 Jun;71(6):3172-82
12761096
Infect Immun. 2003 Nov;71(11):6270-8
14573646
Trends Parasitol. 2003 Nov;19(11):502-8
14580961
Int J Parasitol. 2004 Jul;34(8):899-908
15217728
Infect Immun. 1988 Dec;56(12):3272-9
3182080
Trans R Soc Trop Med Hyg. 1989 Mar-Apr;83(2):189-92
2609368
Exp Parasitol. 1990 May;70(4):427-35
2182337
J Biol Chem. 1990 May 5;265(13):7236-42
2158995
Immunol Today. 1991 Mar;12(3):A58-61
1829891
Mol Biochem Parasitol. 1991 Jul;47(1):109-17
1857379
Rev Infect Dis. 1991 Sep-Oct;13(5):1009-17
1962075
Biochem J. 1992 Jul 1;285 ( Pt 1):41-6
1322126
Curr Opin Immunol. 1992 Aug;4(4):413-8
1356346
Infect Immun. 1993 Jul;61(7):2952-9
8514400
J Clin Invest. 1993 Jul;92(1):324-9
8326000
Infect Immun. 1993 Sep;61(9):3730-8
8359894
Clin Exp Immunol. 1993 Dec;94(3):516-21
7902789
J Clin Invest. 1993 Dec;92(6):2626-32
8254019
Trans R Soc Trop Med Hyg. 1993 Sep-Oct;87(5):550-1
8266406
Infect Immun. 1994 Jun;62(6):2575-81
8188380
Clin Exp Immunol. 1994 Jun;96(3):410-5
8004809
Eur J Immunol. 1994 Nov;24(11):2813-7
7957573
J Exp Med. 1995 Apr 1;181(4):1527-37
7699334
Mol Biochem Parasitol. 1995 Apr;71(1):51-63
7630383
Infect Immun. 1995 Sep;63(9):3559-66
7642292
Infect Immun. 1995 Nov;63(11):4261-7
7591056
Infect Immun. 1995 Dec;63(12):4894-9
7591152
Exp Parasitol. 1996 Nov;84(2):144-55
8932764
J Immunol. 1996 Dec 1;157(11):5034-41
8943412
Infect Immun. 1998 Jul;66(7):3100-5
9632572
Infect Immun. 1998 Jul;66(7):3279-89
9632596
Nat Med. 1998 Dec;4(12):1409-15
9846579
Parasite Immunol. 1999 Apr;21(4):211-8
10320618
J Biol Chem. 2000 May 26;275(21):16366-72
10748102
J Immunol. 2000 Jul 15;165(2):915-24
10878366
J Infect Dis. 2000 Aug;182(2):570-8
10915091
Cytokine. 2000 Aug;12(8):1228-31
10930301
J Biol Chem. 2000 Dec 1;275(48):37789-97
10969068
J Immunol. 2001 Jan 15;166(2):1141-7
11145695
Annu Rev Immunol. 2001;19:683-765
11244051
J Immunol. 2001 Apr 15;166(8):5122-8
11290794
Int J Parasitol. 2002 Apr;32(4):449-59
11849641